Frontlight ResearchEarly access
Trial site
Nottingham University Hospitals City Campus
- 3running trials
- 6closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Lung cancer4 trials
- Phase
- Phase 37 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Daiichi Sankyo5 trials
- Genmab1 trial
- Hoffmann-La Roche1 trial
- Pierre Fabre Medicament1 trial
- Revolution Medicines, Inc.1 trial
Running trials
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Completed
A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)
Terminated
Completed
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026